These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17428628)

  • 21. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.
    Cheng Y; Li M; Xu T
    Eur J Med Chem; 2008 Aug; 43(8):1791-5. PubMed ID: 18215444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermosensitive properties of poly(amidoamine) dendrimers with peripheral phenylalanine residues.
    Tono Y; Kojima C; Haba Y; Takahashi T; Harada A; Yagi S; Kono K
    Langmuir; 2006 May; 22(11):4920-2. PubMed ID: 16700575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.
    Devarakonda B; Otto DP; Judefeind A; Hill RA; de Villiers MM
    Int J Pharm; 2007 Dec; 345(1-2):142-53. PubMed ID: 17600643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PAMAM dendrimer interactions with supported lipid bilayers: a kinetic and mechanistic investigation.
    Parimi S; Barnes TJ; Prestidge CA
    Langmuir; 2008 Dec; 24(23):13532-9. PubMed ID: 18980350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance evaluation of PAMAM dendrimer based simvastatin formulations.
    Kulhari H; Pooja D; Prajapati SK; Chauhan AS
    Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the interactions of PAMAM G3-NH2 and G3-OH dendrimers with 5-fluorouracil in aqueous solutions.
    Buczkowski A; Waliszewski D; Urbaniak P; Palecz B
    Int J Pharm; 2016 May; 505(1-2):1-13. PubMed ID: 27039147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.
    Zhang XQ; Intra J; Salem AK
    Bioconjug Chem; 2007; 18(6):2068-76. PubMed ID: 17848077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes.
    Gardikis K; Hatziantoniou S; Viras K; Wagner M; Demetzos C
    Int J Pharm; 2006 Aug; 318(1-2):118-23. PubMed ID: 16675175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.
    Saovapakhiran A; D'Emanuele A; Attwood D; Penny J
    Bioconjug Chem; 2009 Apr; 20(4):693-701. PubMed ID: 19271737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats.
    Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV
    Biomaterials; 2007 Jan; 28(3):504-12. PubMed ID: 16996126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(amidoamine) dendrimers as skin penetration enhancers: Influence of charge, generation, and concentration.
    Venuganti VV; Perumal OP
    J Pharm Sci; 2009 Jul; 98(7):2345-56. PubMed ID: 18937369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly lipophilic pluronics-conjugated polyamidoamine dendrimer nanocarriers as potential delivery system for hydrophobic drugs.
    Nguyen TTC; Nguyen CK; Nguyen TH; Tran NQ
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 2):992-999. PubMed ID: 27772731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers.
    Filipowicz A; Wołowiec S
    Int J Pharm; 2011 Apr; 408(1-2):152-6. PubMed ID: 21272625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendrimers bind antioxidant polyphenols and cisplatin drug.
    Abderrezak A; Bourassa P; Mandeville JS; Sedaghat-Herati R; Tajmir-Riahi HA
    PLoS One; 2012; 7(3):e33102. PubMed ID: 22427960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin.
    Kono K; Kojima C; Hayashi N; Nishisaka E; Kiura K; Watarai S; Harada A
    Biomaterials; 2008 Apr; 29(11):1664-75. PubMed ID: 18194811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of curcumin and genistein interactions with human serum albumin.
    Mandeville JS; Froehlich E; Tajmir-Riahi HA
    J Pharm Biomed Anal; 2009 Feb; 49(2):468-74. PubMed ID: 19135819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-infrared spectroscopic study on guest-host interactions among G0-G7 amine-terminated poly(amidoamine) dendrimers and porous silica materials for simultaneously determining the molecular weight and particle diameter by multivariate calibration techniques.
    Heigl N; Bachmann S; Petter CH; Marchetti-Deschmann M; Allmaier G; Bonn GK; Huck CW
    Anal Chem; 2009 Jul; 81(14):5655-62. PubMed ID: 19601650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An iron(III) selective dendrite chelator based on polyamidoamine dendrimer modified with 4-bromo-1,8-naphthalimide.
    Grabchev I; Chovelon JM; Petkov C
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jan; 69(1):100-4. PubMed ID: 17451996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro.
    Yellepeddi VK; Kumar A; Palakurthi S
    Anticancer Res; 2009 Aug; 29(8):2933-43. PubMed ID: 19661298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution.
    Buczkowski A; Sekowski S; Grala A; Palecz D; Milowska K; Urbaniak P; Gabryelak T; Piekarski H; Palecz B
    Int J Pharm; 2011 Apr; 408(1-2):266-70. PubMed ID: 21335079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.